New option listings for January 10th include NEXN Stock (NEXN) and AcelRx Pharmaceuticals Inc (TLPH). Option delistings effective January 10th include Audacy, Inc. (AUDA), Athersys Inc (ATHX), and SLGC Stock
New option listings for January 10th include NEXN Stock (NEXN) and AcelRx Pharmaceuticals Inc (TLPH). Option delistings effective January 10th include Audacy, Inc. (AUDA), Athersys Inc (ATHX), and SLGC Stock
Athersys (ATHX) is scheduled to report 3rd quarter earnings on 11/13/2023. Regarding Q3 estimates, Wall Street analysts expect Athersys to post earnings of -$0.21 per share. Last quarter, Athersys missed
17:11 EST Athersys files to sell 76.25M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Assembly Biosciences (ASMB), 11,820% surge in interest Evelo Biosciences
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Athersys (ATHX), 270% surge in interest Acadia (ACAD), 265%